Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study

Barrero Hernández, Francisco Javier; Mallada-Frechin, J; Martínez-Ginés, ML; Marzo, ME; Meca-Lallana, V; Izquierdo, G; Ara, JR; Oreja-Guevara, C; Meca-Lallana, J; Forero, L; Sánchez-Vera, I; Moreno, MJ

doi:10.1371/journal.pone.0230846.

Spanish real-world experience- PLOS-ONE.pdf (1.393Mo)

Identificadores

URI: https://hdl.handle.net/10481/93891

DOI: 10.1371/journal.pone.0230846.

Exportar

Editorial

PLOS

Date

2020-04

Referencia bibliográfica

Barrero F, Mallada-Frechin J, Martínez-Ginés ML, Marzo ME, Meca-Lallana V, Izquierdo G, Ara JR, Oreja-Guevara C, Meca-Lallana J, Forero L, Sánchez-Vera I, Moreno MJ; in representation of the MS NEXT study investigators. Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study. PLoS One. 2020 Apr 2;15(4):e0230846. doi: 10.1371/journal.pone.0230846. PMID: 32240213; PMCID: PMC7117743.

Colecciones

DMed - Artículos

Excepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 Internacional